U.S. stocks advanced across the board by midday Friday, with the S&P 500 eyeing its ninth consecutive day of gains—poised for the longest winning streak since May 2024.
Cigna posts strong Q1 results with rising sales at Evernorth and Cigna Healthcare; raises 2025 EPS outlook to $29.60 amid higher medical cost ratio expectations.
AstraZeneca said on Friday that the full results from the two trials will be shared with regulatory authorities and presented at an upcoming medical meeting.
Health insurance company Cigna (NYSE:CI) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 14.4% year on year to $65.5 billion. Its non-GAAP profit of $6.74 per share was 6.2% above analysts’ consensus estimates.
The spotlight will likely be on the April non-farm payrolls report. Economists, on average, expect 133,000 job gains for the month, notably slower than the 228,00 pace for March.
UnitedHealthcare Group is the best house in a rough neighborhood as its still a very profitable vertically integrated healthcare company, not just an insurer.
Canada’s Competition Bureau is investigating allegations of conduct that can prevent or limit competition in the pharmacy retail market, including “patient steering” and “margin squeezing.”
Let's have a look at what is happening on the US markets one hour before the close of the markets on Thursday. Below you can find the top S&P500 gainers and losers in today's session.
Since October 2024, Cigna has been in a holding pattern, posting a small loss of 1% while floating around $338.25. However, the stock is beating the S&P 500’s 6.9% decline during that period.
The FTC has paused its antitrust case against major PBMs, citing a lack of commissioners. The lawsuit alleges unfair practices that inflated insulin prices.
